Bio Similars & Waivers

Biosimilars & Biowaivers

Biosimilar Insulin

The Biosimilar insulin (BIs) are viewed as upcoming commercially attractive products by a number of corporates. But in order to obtain approval in EU or US, its safety and efficacy profile must be demonstrates and it should be in tune with the Read more…

Be the first to comment - What do you think?
Posted by John Mecila - 01/11/2012 at 03:36

Categories: Bio Similars & Waivers, Medical, Pharmaceutical Sciences   Tags: , , ,